Charles R. Horsburgh, Jr.

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine at Boston University. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is the Vice-President of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Contact

See biography

Publications

Li, Y., Regan, M., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Miller, J., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Disparities in tuberculosis incidence by race and ethnicity among the U.S.-born population in the United States, 2011 to 2021: An analysis of national disease registry data. Annals of Internal Medicine, 177(4), 418-427. https://doi.org/10.7326/M23-2975
Regan, M., Barham, T., Li, Y., Swartwood, N., Beeler Asay, G., Cohen, T., Horsburgh, C., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., Winston, C., & Menzies, N. (2024). Risk factors underlying racial and ethnic disparities in tuberculosis diagnosis and treatment outcomes, 2011-19: A multiple mediation analysis of national surveillance data. Lancet Public Health, 9(8), e564-e572. https://doi.org/10.1016/S2468-2667(24)00151-8
Menzies, N., Swartwood, N., Cohen, T., Marks, S., Maloney, S., Chappelle, C., Miller, J., Beeler Asay, G., Date, A., Horsburgh, C., & Salomon, J. (2024). The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: A mathematical modelling study. Lancet Public Health, 9(8), e573-e582. https://doi.org/10.1016/S2468-2667(24)00150-6
Ekramnia, M., Li, Y., Haddad, M., Marks, S., Kammerer, J., Swartwood, N., Cohen, T., Miller, J., Horsburgh, C., Salomon, J., & Menzies, N. (2024). Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. Epidemiology, 35(2), 164-173. https://doi.org/10.1097/EDE.0000000000001707
Regan, M., Li, Y., Swartwood, N., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003–19: An analysis of national surveillance data. The Lancet Public Health, 9(1), e47-e56. https://doi.org/10.1016/S2468-2667(23)00276-1
Kim, S., Cohen, T., Horsburgh, C., Miller, J., Hill, A., Marks, S., Li, R., Kammerer, J., Salomon, J., & Menzies, N. (2022). Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clinical Infectious Diseases, 74(9), 1594–1603. https://doi.org/10.1093/cid/ciab668
Epstein, R., Wang, J., Mayer, K., Puro, J., Horsburgh, C., Linas, B., & Assoumou, S. (2018). HCV screening practices among adolescents and young adults in a national sample of federally qualified health centers in the United States. Open Forum Infectious Diseases, 5, S74. https://doi.org/10.1093/ofid/ofy209.178
Tasillo, A., Salomon, J., Trikalinos, T., Horsburgh, C., Marks, S., & Linas, B. (2017). Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model. JAMA Internal Medicine, 177(12), 1755-1764. https://doi.org/10.1001/jamainternmed.2017.3941